JULY 23, 2018

Company

SELLAS Life Sciences Group, Inc.

Filed

July 23, 2018

Accession Number

0001013594-18-000463

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →